Heron Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 3,700 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 2,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 3,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Option
DAVIS STEPHEN director
Stock Option (Right to Buy) 120,313 N/A N/A
Option
DAVIS STEPHEN director
Common Stock 120,313 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 10 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 3,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 4,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 3,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 3,300 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 4,000 N/A N/A
Purchase
TANG KEVIN C director
Common Stock 510,638 N/A N/A
Purchase
QUART BARRY D director, officer: Chief Execut..
Common Stock 10,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 19,147 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SPCH, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 2,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 1,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 4,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 3,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 5,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 10,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 10,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 2,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 4,000 N/A N/A
Sale
SAVITR CAPITAL, LLC other: Exiting 10% holder
Heron Therapeutics Common Stock 9,000 N/A N/A
Purchase
QUART BARRY D director, officer: Chief Execut..
Common Stock 1,000,000 N/A N/A
Option
WHELAN JOHN officer: CFO
Incentive Stock Option (right to buy) 254,088 N/A N/A
Option
WHELAN JOHN officer: CFO
Common Stock 254,088 N/A N/A
Purchase
SPCH, LLLP
A.P. Pharma Common Stock 38,095,238 N/A N/A
Purchase
BAKER BROS. CAPITAL (GP), LLC 10 percent owner
Rights to Purchase Senior Secured Convertible Notes due 2021 600 N/A N/A
Purchase
14159 CAPITAL (GP), LLC 10 percent owner
Rights to Purchase Senior Secured Convertible Notes due 2021 10,800 N/A N/A
Purchase
14159 CAPITAL (GP), LLC 10 percent owner
Senior Secured Convertible Notes due 2021 5,400 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC 10 percent owner
Rights to Purchase Senior Secured Convertible Notes due 2021 588,600 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC 10 percent owner
Senior Secured Convertible Notes due 2021 294,300 N/A N/A
Purchase
BAKER BROS. CAPITAL (GP), LLC 10 percent owner
Senior Secured Convertible Notes due 2021 300 N/A N/A
Purchase
TANG KEVIN C director
Purchase Rights (right to buy) 1,586,481 N/A N/A

Showing 300 to 350 of 375 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.